BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22363533)

  • 1. Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint control.
    Thanasopoulou A; Stravopodis DJ; Dimas KS; Schwaller J; Anastasiadou E
    PLoS One; 2012; 7(2):e31007. PubMed ID: 22363533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of CCDC6 reduces the expression of 14-3-3σ in colorectal carcinoma cells.
    Thanasopoulou A; Xanthopoulou AG; Anagnostopoulos AK; Konstantakou EG; Margaritis LH; Papassideri IS; Stravopodis DJ; Tsangaris GT; Anastasiadou E
    Anticancer Res; 2012 Mar; 32(3):907-13. PubMed ID: 22399611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CCDC6, the first identified RET partner gene, affects pH2AX S139 levels and accelerates mitotic entry upon DNA damage.
    Merolla F; Luise C; Muller MT; Pacelli R; Fusco A; Celetti A
    PLoS One; 2012; 7(5):e36177. PubMed ID: 22655027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epithelium specific cell cycle regulator 14-3-3sigma is required for preventing entry into mitosis following ultraviolet B.
    Vogel S; Herzinger T
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):300-10. PubMed ID: 24102700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition.
    Meng S; Arbit T; Veeriah S; Mellinghoff IK; Fang F; Vivanco I; Rohle D; Chan TA
    Cell Cycle; 2009 Jul; 8(14):2238-46. PubMed ID: 19502805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Cdc25B regulates cell cycle resumption after genotoxic stress.
    Bansal P; Lazo JS
    Cancer Res; 2007 Apr; 67(7):3356-63. PubMed ID: 17409445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
    Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
    Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cancer cell death induced by depletion of an essential replication regulator.
    Ito S; Ishii A; Kakusho N; Taniyama C; Yamazaki S; Fukatsu R; Sakaue-Sawano A; Miyawaki A; Masai H
    PLoS One; 2012; 7(5):e36372. PubMed ID: 22574151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression.
    Bugler B; Quaranta M; Aressy B; Brezak MC; Prevost G; Ducommun B
    Mol Cancer Ther; 2006 Jun; 5(6):1446-51. PubMed ID: 16818502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.
    Luise C; Merolla F; Leone V; Paladino S; Sarnataro D; Fusco A; Celetti A
    PLoS One; 2012; 7(11):e49298. PubMed ID: 23145146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C.
    Singh SV; Herman-Antosiewicz A; Singh AV; Lew KL; Srivastava SK; Kamath R; Brown KD; Zhang L; Baskaran R
    J Biol Chem; 2004 Jun; 279(24):25813-22. PubMed ID: 15073169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 14-3-3beta but not 14-3-3sigma controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B.
    Uchida S; Kuma A; Ohtsubo M; Shimura M; Hirata M; Nakagama H; Matsunaga T; Ishizaka Y; Yamashita K
    J Cell Sci; 2004 Jun; 117(Pt 14):3011-20. PubMed ID: 15173315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC.
    Morra F; Luise C; Merolla F; Poser I; Visconti R; Ilardi G; Paladino S; Inuzuka H; Guggino G; Monaco R; Colecchia D; Monaco G; Cerrato A; Chiariello M; Denning K; Claudio PP; Staibano S; Celetti A
    Oncotarget; 2015 May; 6(14):12697-709. PubMed ID: 25885523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 Gamma is required to enforce both the incomplete S phase and G2 DNA damage checkpoints.
    Hosing AS; Kundu ST; Dalal SN
    Cell Cycle; 2008 Oct; 7(20):3171-9. PubMed ID: 18843201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
    Reinhardt HC; Aslanian AS; Lees JA; Yaffe MB
    Cancer Cell; 2007 Feb; 11(2):175-89. PubMed ID: 17292828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence.
    Schultz J; Ibrahim SM; Vera J; Kunz M
    Mol Cancer; 2009 Jul; 8():53. PubMed ID: 19642975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G
    Shen Y; Sherman JW; Chen X; Wang R
    J Biol Chem; 2018 Apr; 293(14):5185-5199. PubMed ID: 29467227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells.
    Andreassen PR; Lacroix FB; Lohez OD; Margolis RL
    Cancer Res; 2001 Oct; 61(20):7660-8. PubMed ID: 11606409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage response in lung cancer cells.
    Zhao J; Tang J; Men W; Ren K
    FEBS Lett; 2012 Dec; 586(24):4257-63. PubMed ID: 23108047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks.
    Sert V; Cans C; Tasca C; Bret-Bennis L; Oswald E; Ducommun B; De Rycke J
    Oncogene; 1999 Nov; 18(46):6296-304. PubMed ID: 10597228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.